Sangamo, Novartis Make Gene Therapy Deal for Brain Disorders
(Bloomberg) -- Small-cap drug developer Sangamo Therapeutics Inc. jumped after striking a deal with Novartis AG to develop gene therapies for disorders attacking the brain and central nervous syste...